Brimonidine Tartrate Ophthalmic Solution

FDA Drug Profile — Brimonidine Tartrate Ophthalmic Solution

Brimonidine Tartrate Ophthalmic Solution is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Brimonidine Tartrate Ophthalmic Solution. Available dosage form: solution/ drops.

Drug details

Generic Name
Brimonidine Tartrate Ophthalmic Solution
Brand Names
Brimonidine Tartrate Ophthalmic Solution
Application Number
ANDA220398
Sponsor
Lifestar Pharma LLC
NDC Codes
6
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
BRIMONIDINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Brimonidine tartrate ophthalmic solution 0.1% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brimonidine tartrate ophthalmic solution is an alpha adrenergic agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.